SUBSCRIBE
SUBSCRIBE
News   Deals

AstraZeneca PLC (JOBS) CEO Says Firm Mulls Branded Generic Buy in Emerging Markets

September 24, 2008 | 
1 min read
LONDON (MarketWatch) -- AstraZeneca PLC will consider acquiring branded generic drugs in emerging countries as it boosts its business outside the U.S. and Europe, Chief Executive David Brennan said Tuesday.
Mergers & acquisitions Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Podcast
CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP
July 2, 2025
 · 
1 min read
 · 
Heather McKenzie
Contemporary art collage, female palms in the orange circle, a bag of money. Concept of business and finance.
Mergers & acquisitions
AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies
June 30, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Brain with lightning, brainstorming vector icon vector icon
Alzheimer’s disease
Alzheimer’s Deals Surged 780% After Leqembi, Kisunla Broke Approval Stalemate
June 30, 2025
 · 
2 min read
 · 
Annalee Armstrong
Illustration of employer’s hand holding employee who was laid off to drop him out of office
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
June 30, 2025
 · 
1 min read
 · 
Tristan Manalac